HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Asialoerythropoietin is a strong modulator of angiogenesis by bone-marrow cells.

Abstract
The angiogenetic effect of asialoerythropoietin (asialoEPO) was investigated in a murine (BALB/c) ischemic hind limb model created by ligating the right femoral artery, and severe ischemia was created by ligating two points on the femoral artery. The mice were allocated to six groups: 1, Control (n = 15), no treatment; 2, BMC (n = 15), Injected with 1 x 10(6) bone marrow cells (BMC); 3, EPO (n = 15), EPO(500 U/kg for 2 weeks); 4, BMC + EPO (n = 15), BMC + erythropoietin (EPO); 5, asialoEPO (n = 15), asialoEPO (500 U/kg for 2 weeks); 6, BMC + asialoEPO (n = 15); BMC + asialoEPO. Blood flow in the ischemic and normal limbs was measured using a Doppler flowmeter on days 7 and 14. Vessel density was evaluated by immunohistochemical staining for Von Willebrand Factor (vWF). In the severe ischemia model, limb survival was investigated. Blood flow was significantly higher in the BMC + asialoEPO group than in the Control, BMC, EPO, BMC + EPO, or asialoEPO group on day 7 (p = .007) and on day 14 (p = .002). Vascular density was also significantly higher in the BMC + asialoEPO (0.067 +/- 0.022) group than in the Control (0.026 +/- 0.007), BMC (0.027 +/- 0.012) EPO (0.029 +/- 0.002), BMC + EPO (0.048 +/- 0.015), and asialoEPO (0.031 +/- 0.001) groups (p = .006). Finally, limb survival at day 14 in the severe ischemia model was significantly better in the BMC + asialoEPO group (83.3%) than in the Control (40.0%), BMC (52.9%), EPO (44.4%), BMC + EPO (64.7%), or asialoEPO (36.4%) group (p = .02). This provides the conclusions that asialoEPO promotes angiogenesis by BMC and that its action is significantly more potent than that of EPO.
AuthorsShozo Mori, Tokihiko Sawada, Keiichi Kubota
JournalJournal of investigative surgery : the official journal of the Academy of Surgical Research (J Invest Surg) 2007 Nov-Dec Vol. 20 Issue 6 Pg. 357-62 ISSN: 0894-1939 [Print] United States
PMID18097877 (Publication Type: Journal Article)
Chemical References
  • Asialoglycoproteins
  • asialoerythropoietin
  • Erythropoietin
Topics
  • Animals
  • Asialoglycoproteins (pharmacology)
  • Bone Marrow Cells (physiology)
  • Erythropoietin (analogs & derivatives, pharmacology)
  • Hindlimb (blood supply)
  • Mice
  • Mice, Inbred BALB C
  • Neovascularization, Physiologic (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: